AC
AI Cancer Cure
Evidence Atlas, updating nightly
Trials
Research
Support
Alternatives
Cancers
Biomarkers
Updates
Roadmap
Explore
← Back to trials
Trial not found
Could not find
NCT05314296
in the database yet.
Osimertinib for Russian EGFR T790M Mutation-positive NSCLC Patients Who Progressed on or After EGFR TKI Therapy | AI Cancer Cure